What Are Insmed Incorporated's Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $606 million | $364 million | $305 million | $245 million |
| Operating income | -$1.2 billion | -$878 million | -$710 million | -$457 million |
| Operating margin | -205.6% | -241.5% | -232.5% | -186.4% |
| Net income | -$1.3 billion | -$914 million | -$750 million | -$482 million |
| Net margin | -210.5% | -251.2% | -245.6% | -196.3% |
| Operating cash flow | -$935 million | -$684 million | -$536 million | -$400 million |
| Capital expenditures | $33 million | $22 million | $13 million | $10 million |
| Free cash flow | -$968 million | -$706 million | -$550 million | -$410 million |
Operating margin widened by 35.9 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was -$968 million against net income of -$1.3 billion; cash generation covered reported earnings.
What Does Insmed Incorporated's Balance Sheet Show?
| Cash and cash equivalents | $510 million |
|---|---|
| Long-term debt | $541 million |
| Total assets | $2.3 billion |
| Total liabilities | $1.5 billion |
| Shareholders' equity | $739 million |
| Current ratio | 3.8x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Insmed Incorporated reported in its own SEC filings, read from the SEC's XBRL data (accession 0001104506-26-000009 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Insmed Incorporated's revenue in fiscal 2025?
Insmed Incorporated reported revenue of $606 million for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Insmed Incorporated's operating margin?
Insmed Incorporated's operating margin was -205.6% in fiscal 2025: operating income of -$1.2 billion on revenue of $606 million.
How much free cash flow did Insmed Incorporated generate?
Operating cash flow of -$935 million less capital expenditures of $33 million gives free cash flow of -$968 million for fiscal 2025.